Revance Therapeutics, Inc. Annual Return On Assets in % from 2014 to 2023

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Revance Therapeutics, Inc. quarterly/annual Return On Assets history and growth rate from 2014 to 2023.
  • Revance Therapeutics, Inc. Return On Assets for the quarter ending June 30, 2024 was -57.1 %, a 2.68% increase year-over-year.
  • Revance Therapeutics, Inc. annual Return On Assets for 2023 was -60.1 %, a 5.18% decline from 2022.
  • Revance Therapeutics, Inc. annual Return On Assets for 2022 was -57.1 %, a 23.4% decline from 2021.
  • Revance Therapeutics, Inc. annual Return On Assets for 2021 was -46.3 %, a 6.78% decline from 2020.
Return On Assets, Annual (%)
Return On Assets, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -60.1 -2.96 -5.18% Jan 1, 2023 Dec 31, 2023
2022 -57.1 -10.8 -23.4% Jan 1, 2022 Dec 31, 2022
2021 -46.3 -2.94 -6.78% Jan 1, 2021 Dec 31, 2021
2020 -43.4 +8.62 +16.6% Jan 1, 2020 Dec 31, 2020
2019 -52 +4.84 +8.52% Jan 1, 2019 Dec 31, 2019
2018 -56.8 -0.84 -1.5% Jan 1, 2018 Dec 31, 2018
2017 -56 -17.5 -45.4% Jan 1, 2017 Dec 31, 2017
2016 -38.5 -1.23 -3.3% Jan 1, 2016 Dec 31, 2016
2015 -37.3 -2.89 -8.4% Jan 1, 2015 Dec 31, 2015
2014 -34.4 Jan 1, 2014 Dec 31, 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.